Allianz Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.6M | Sell |
85,600
-1,700
| -2% | -$377K | 0.02% | 642 |
|
|
2025
Q4 | $19.9M | Buy |
87,300
+11,400
| +15% | +$2.6M | 0.02% | 607 |
|
|
2025
Q3 | $17.6M | Buy |
75,900
+9,200
| +14% | +$1.87M | 0.02% | 638 |
|
|
2025
Q2 | $12.4M | Sell |
66,700
-24,900
| -27% | -$4.63M | 0.01% | 742 |
|
|
2025
Q1 | $19.2M | Buy |
91,600
+25,500
| +39% | +$4.96M | 0.03% | 587 |
|
|
2024
Q4 | $11.7M | Sell |
66,100
-5,300
| -7% | -$974K | 0.02% | 703 |
|
|
2024
Q3 | $14.1M | Buy |
71,400
+15,500
| +28% | +$2.89M | 0.02% | 628 |
|
|
2024
Q2 | $9.59M | Buy |
55,900
+51,000
| +1,041% | +$8.45M | 0.01% | 706 |
|
|
2024
Q1 | $892K | Sell |
4,900
-43,100
| -90% | -$7.43M | ﹤0.01% | 1452 |
|
|
2023
Q4 | $7.44M | Sell |
48,000
-79,500
| -62% | -$11.6M | 0.01% | 780 |
|
|
2023
Q3 | $19M | Sell |
127,500
-8,300
| -6% | -$1.22M | 0.03% | 510 |
|
|
2023
Q2 | $18.3M | Buy |
135,800
+65,200
| +92% | +$9.56M | 0.03% | 485 |
|
|
2023
Q1 | $11.3M | Buy |
70,600
+25,300
| +56% | +$3.87M | 0.02% | 651 |
|
|
2022
Q4 | $7.32M | Buy |
45,300
+21,900
| +94% | +$3.36M | 0.01% | 787 |
|
|
2022
Q3 | $3.14M | Buy |
23,400
+10,400
| +80% | +$1.49M | 0.01% | 1081 |
|
|
2022
Q2 | $1.99M | Sell |
13,000
-53,300
| -80% | -$8.14M | ﹤0.01% | 1422 |
|
|
2022
Q1 | $10.7M | Buy |
66,300
+46,300
| +232% | +$6.73M | 0.01% | 968 |
|
|
2021
Q4 | $2.71M | Sell |
20,000
-65,900
| -77% | -$7.78M | ﹤0.01% | 1491 |
|
|
2021
Q3 | $9.27M | Buy |
85,900
+34,300
| +66% | +$3.92M | 0.01% | 1047 |
|
|
2021
Q2 | $5.81M | Buy |
+51,600
| New | +$5.81M | ﹤0.01% | 1053 |
|
|
2020
Q3 | – | Sell |
-145,900
| Closed | -$14.3M | – | 1834 |
|
|
2020
Q2 | $14.3M | Buy |
145,900
+22,000
| +18% | +$1.94M | 0.02% | 755 |
|
|
2020
Q1 | $9.44M | Sell |
123,900
-53,300
| -30% | -$4.54M | 0.01% | 876 |
|
|
2019
Q4 | $15.7M | Sell |
177,200
-11,400
| -6% | -$946K | 0.01% | 900 |
|
|
2019
Q3 | $14.3M | Buy |
188,600
+19,500
| +12% | +$1.34M | 0.01% | 927 |
|
|
2019
Q2 | $12.3M | Buy |
169,100
+55,900
| +49% | +$4.39M | 0.01% | 1081 |
|
|
2019
Q1 | $9.12M | Sell |
113,200
-24,700
| -18% | -$2.02M | 0.01% | 1185 |
|
|
2018
Q4 | $12.7M | Sell |
137,900
-57,000
| -29% | -$5.01M | 0.01% | 987 |
|
|
2018
Q3 | $18.4M | Sell |
194,900
-30,100
| -13% | -$2.85M | 0.02% | 942 |
|
|
2018
Q2 | $20.8M | Buy |
225,000
+150,000
| +200% | +$14.6M | 0.02% | 865 |
|
|
2018
Q1 | $7.1M | Buy |
75,000
+18,500
| +33% | +$2.03M | 0.01% | 1393 |
|
|
2017
Q4 | $5.46M | Sell |
56,500
-90,600
| -62% | -$8.54M | ﹤0.01% | 1581 |
|
|
2017
Q3 | $13.1M | Buy |
147,100
+48,400
| +49% | +$3.68M | 0.01% | 1194 |
|
|
2017
Q2 | $7.16M | Buy |
98,700
+200
| +0.2% | +$13.4K | 0.01% | 1446 |
|
|
2017
Q1 | $6.42M | Sell |
98,500
-412,300
| -81% | -$25.9M | 0.01% | 1518 |
|
|
2016
Q4 | $32M | Buy |
510,800
+113,500
| +29% | +$6.93M | 0.03% | 775 |
|
|
2016
Q3 | $25.1M | Buy |
397,300
+124,100
| +45% | +$8.03M | 0.02% | 837 |
|
|
2016
Q2 | $16.9M | Buy |
273,200
+169,200
| +163% | +$10.3M | 0.02% | 990 |
|
|
2016
Q1 | $5.94M | Buy |
104,000
+40,800
| +65% | +$2.27M | 0.01% | 1374 |
|
|
2015
Q4 | $3.74M | Buy |
63,200
+30,200
| +92% | +$1.74M | ﹤0.01% | 1467 |
|
|
2015
Q3 | $1.8M | Sell |
33,000
-44,900
| -58% | -$2.92M | ﹤0.01% | 1628 |
|
|
2015
Q2 | $5.23M | Buy |
77,900
+41,200
| +112% | +$2.69M | 0.01% | 1371 |
|
|
2015
Q1 | $2.15M | Sell |
36,700
-34,700
| -49% | -$2.1M | ﹤0.01% | 1504 |
|
|
2014
Q4 | $4.67M | Buy |
71,400
+51,600
| +261% | +$3.25M | 0.01% | 1244 |
|
|
2014
Q3 | $1.14M | Buy |
+19,800
| New | +$1.1M | ﹤0.01% | 1623 |
|
Other funds holding ABBV
VCM
VPM
Allianz Asset Management's ABBV Position: Q1 2026 in Review
Allianz Asset Management increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $29.9M and bringing the position to 1,393,938 shares worth $303M. The position accounts for 0.32% of the portfolio, ranked #61.
Allianz Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $863M in Q2 2015. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Allianz Asset Management held 1,393,938 shares of AbbVie worth $303M as of Q1 2026.
- Allianz Asset Management bought 134,715 AbbVie shares in Q1 2026, an estimated $29.9M.
- AbbVie made up 0.32% of Allianz Asset Management's portfolio in Q1 2026, its #61 holding.
- Allianz Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's AbbVie position peaked at $863M in Q2 2015.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.